RAYDEL Australia Named Finalist in Two Categories at 2025 NSW Export Awards

RAYDEL Australia, the dedicated manufacturing headquarters for our premium health solutions, has been named a finalist in two prestigious categories at the 2025 NSW Export Awards: International Health and NSW Exporter to Asia. Presented by the Export Council of Australia and now in its 63rd year, this program celebrates the innovation and global success of New South Wales-based exporters.

World-Class Manufacturing from Australia to Singapore

This recognition highlights the excellence of RAYDEL Australia’s state-of-the-art, GMP-certified facility. By managing the entire production process in Australia, the company ensures that flagship products like Policosanol and Abexol are manufactured under the highest international safety and quality standards.

Recognized Categories

The double nomination underscores RAYDEL’s outstanding achievements in specialized fields:

• International Health: This national category recognizes success in medical technology, wellbeing, and biotechnology.

• NSW Exporter to Asia: This state category honors exceptional export achievement by NSW-based businesses within Asian markets.

Commitment to Scientific Integrity

These nominations affirm RAYDEL’s mission to provide evidence-based wellness solutions backed by significant clinical research. This achievement reflects the growing impact of the brand's scientific integrity and manufacturing excellence within the Singaporean and broader Asian markets.